GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines

GlaxoSmithKline Pharmaceuticals

15/10/2024 14:57

Oct 15 (Reuters) - GlaxoSmithKline  GLAX.NS  sued
Moderna  MRNA.O  in Delaware federal court on Tuesday for
allegedly violating GSK's patent rights in messenger RNA (mRNA)
technology with its blockbuster COVID-19 vaccine Spikevax.
    The lawsuit said Moderna's lipid nanoparticles for
transporting mRNA into the human body infringe several GSK
patents covering similar innovations. GSK filed a related
lawsuit against Pfizer and BioNTech in the same court in April
over their COVID-19 vaccines.
     

 (Reporting by Blake Brittain)
 ((mailto:blake.brittain@thomsonreuters.com;))